Skip to main content

Table 1 Univariate logistic analyses, variables associated with all-cause 30-day in-hospital mortality

From: Complex clinical and microbiological effects on Legionnaires’ disease outcome; A retrospective cohort study

Parametersa,

Alive (N = 60)

Dead (N = 11)

OR, 95 % CI

P-value

Demography

    

Age, years, mean ± SD

65.7 ± 15.5

74.6 ± 9.5

1.05, 1.0–1.10

0.08

Male sexb

42 (70.0)

8 (72.7)

0.88, 0.21–3.68

0.86

Predisposing conditions

    

Nonec

7 (11.7)

0

-

1.00

Myocardial infarctionc,d

21 (35.0)

5 (45.5)

1.55, 0.42–5.68

0.51

Congestive heart failurec,d

8 (13.3)

4 (36.4)

3.71, 0.88–15.62

0.07

Chronic pulmonary diseasec,d

13 (21.7)

2 (18.2)

0.08, 0.15–4.19

0.80

Diabetesc,d

17 (28.3)

2 (18.2)

0.56, 0.11–2.87

0.49

Leukemiac,d

4 (6.7)

4 (36.4)

8.0, 1.63–39.35

0.01

Lymphomac,d

3 (5)

2 (18.2)

4.22, 0.62–28.87

0.14

Solid tumorc,d

6 (10)

0

-

0.58

Metastatic cancerc,d

2 (3.3)

1 (9.1)

2.9, 0.24–35.07

0.40

Steroid treatmentc, e

7 (11.7)

3 (27.3)

2.84, 0.61–13.30

0.19

Chemotherapyc, e

7 (11.7)

3 (27.3)

2.84, 0.61–13.30

0.19

Current smokerc

23 (38.3)

2 (18.2)

0.36, 0.07–1.80

0.21

Ever smokedc

35 (58.3)

6 (54.5)

0.86, 0.24–3.12

0.82

Hospitalization within 30 daysc

6 (10)

4 (36.4)

5.14, 1.16–22.82

0.03

Charlson comorbidity index, mean ± SD

2.3 ± 2.1

3.7 ± 2.1

1.33, 1.00–1.77

0.05

Laboratory variables at admission

    

Oxygen saturation, %, mean ±SD

92.1 ± 5.2

88.3 ± 10.7

0.92, 0.83–1.02

0.12

Neutrophil count < 1.0 x109/Lc

2 (18.2)g

7 (10.0)

2.4, 0.40–14.31

0.34

Lymphocyte count < 1.0 x109/Lc

38 (64.4)g

5 (45.5)

0.46, 0.13–1.69

0.24

Creatinine level, μmol/L, mean ± SD

123.8 ± 70.7

168.0 ± 106.1

1.60, 0.88–2.89

0.12

Bilateral infiltrates on chest X-rayc

14 (23.3)

4 (36.4)

1.88, 0.48–7.36

0.37

Primary diagnosis by positive UATf

14 (23.3)

7 (63.6)

0.17, 0.04–0.68

0.01

Antibiotic therapy & outcome

    

Appropriate therapy on day +1c

37 (61.7)

3 (27.3)

0.23, 0.06–0.98

0.05

Appropriate therapy on day +2 c

52 (86.7)

4 (36.4)

0.09, 0.02–0.37

0.001

Delay in appropriate therapy administration, days, mean ± SD

0.9 ± 1.8

4.2 ± 5.6

1.34, 1.08–1.67

0.01

Quinolones started on day +1c

17 (28.3)

3 (27.3)

1.13, 0.26–4.80

0.87

Quinolones started on day +2c

23 (38.3)

4 (36.4)

0.92, 0.24–3.49

0.90

ICU admissionc

12 (20.0)

9 (81.8)

18.00, 3.43–94.44

0.001

Invasive ventilation c

10 (16.7)

8 (72.7)

13.33, 3.00–59.19

0.001

  1. Abbreviations: OR odds ratio, CI confidence interval, SD standard deviation, ICU intensive care unit
  2. aNo.(%) unless otherwise stated
  3. bReference category: female sex
  4. cReference category: no
  5. dVariables included in the Charlson comorbidity score
  6. eWithin 30 days preceding hospitalization
  7. fReference category: primary diagnosis by positive culture
  8. gMissing data = 1